Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis

被引：0
作者：
Jin, Zhong [1 ]
Xu, Naijin [2 ]
Guo, Kai [1 ]
Xu, Peng [1 ]
Li, Pengju [1 ]
Zhang, Yiming [1 ]
Li, Xiezhao [1 ]
Zheng, Shaobo [1 ]
Liu, Chunxiao [1 ]
Xu, Abai [1 ]
Huang, Peng [1 ]
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou 510282, Guangdong, Peoples R China
[2] Dalian Med Univ, Hosp 2, Dept Urol 1, Dalian, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 04期
关键词：
MACC1; renal cell carcinoma; prognosis; biomarker; INTERFERON-ALPHA; PREDICTS; THERAPY; MACC1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Metastasis-associated in colon cancer-1 (MACC1) expression in tumor specimens is an independent prognostic indicator of metastasis, which has recently gained considerable attention in cancer research, due to its overexpression in several types of carcinoma. However, MACC1 expression patterns and its possible role in renal cell carcinoma remain unknown. This study aimed to investigate MACC1 expression in renal cell carcinoma via immunohistochemical analysis and determine the relationship between MACC1 expression and cancer prognosis. Positive MACC1 expression was found to significantly correlate with distant metastasis and TNM stage (P < 0.05). A Kaplan-Meier survival analysis revealed that patients with higher MACC1 expression had a significantly lower disease-free rate (P < 0.05). These results indicate that MACC1 expression is significantly associated with prognosis in patients with renal cell carcinoma. To the best of our knowledge, this is the first study on the significance of MACC1 as a prognostic marker in renal cell carcinoma. MACC1 expression may be a useful target for the development of new therapeutic approaches, including molecular targeted therapeutic agents, for renal cell carcinoma.
引用
收藏
页码：3857 / 3863
页数：7
相关论文
共 16 条
[1]  
[Anonymous], NEW ENGL J MED
[2]   Colon cancer metastasis: MACC1 and Met as metastatic pacemakers [J].
Arlt, Franziska ;
Stein, Ulrike .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (12) :2356-2359
[3]   Recent developments in the treatment of renal cell carcinoma [J].
Dutcher, Janice P. .
THERAPEUTIC ADVANCES IN UROLOGY, 2013, 5 (06) :338-353
[4]   Novel Pathways and Molecular Targets for the Treatment of Sarcoma [J].
Frith, Ashley E. ;
Hirbe, Angela C. ;
Van Tine, Brian A. .
CURRENT ONCOLOGY REPORTS, 2013, 15 (04) :378-385
[5]   Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma [J].
Huang, P. ;
Kaku, H. ;
Chen, J. ;
Kashiwakura, Y. ;
Saika, T. ;
Nasu, Y. ;
Urata, Y. ;
Fujiwara, T. ;
Watanabe, M. ;
Kumon, H. .
CANCER GENE THERAPY, 2010, 17 (07) :484-491
[6]   Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence [J].
Huang, Peng ;
Chen, Jie ;
Wang, Lei ;
Na, Yanqun ;
Kaku, Haruki ;
Ueki, Hideo ;
Sasaki, Katsumi ;
Yamaguchi, Ken ;
Zhang, Kai ;
Saika, Takashi ;
Nasu, Yasutomo ;
Watanabe, Masami ;
Kumon, Hiromi .
MEDICAL ONCOLOGY, 2012, 29 (02) :829-834
[7]   Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma [J].
Hudes, Gary ;
Carducci, Michael ;
Tomczak, Piotr ;
Dutcher, Janice ;
Figlin, Robert ;
Kapoor, Anil ;
Staroslawska, Elzbieta ;
Sosman, Jeffrey ;
McDermott, David ;
Bodrogi, Istvan ;
Kovacevic, Zoran ;
Lesovoy, Vladimir ;
Schmidt-Wolf, Ingo G. H. ;
Barbarash, Olga ;
Gokmen, Erhan ;
O'Toole, Timothy ;
Lustgarten, Stephanie ;
Moore, Laurence ;
Motzer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) :2271-2281
[8]   Adjuvant Therapy in Renal Cell Carcinoma-Past, Present, and Future [J].
Janowitz, Tobias ;
Welsh, Sarah J. ;
Zaki, Kamarul ;
Mulders, Peter ;
Eisen, Tim .
SEMINARS IN ONCOLOGY, 2013, 40 (04) :482-491
[9]   Cancer statistics, 2007 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Murray, Taylor ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66
[10]   Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Tomczak, Piotr ;
Michaelson, M. Dror ;
Bukowski, Ronald M. ;
Rixe, Olivier ;
Oudard, Stephane ;
Negrier, Sylvie ;
Szczylik, Cezary ;
Kim, Sindy T. ;
Chen, Isan ;
Bycott, Paul W. ;
Baum, Charles M. ;
Figlin, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :115-124
12